Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.
(2005) 2005 ASCO Annual Meeting In Journal of Clinical Oncology 23(16S). p.841-841
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/226787
- author
- Tanner, MM ; Isola, JJ ; Wiklund, T ; Erikstein, B ; Kellokumpu-Lehtinen, P ; Malmström, Per LU ; Wilking, N ; Nilsson, J and Bergh, J
- organization
- publishing date
- 2005
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Clinical Oncology
- volume
- 23
- issue
- 16S
- pages
- 841 - 841
- publisher
- American Society of Clinical Oncology
- conference name
- 2005 ASCO Annual Meeting
- conference dates
- 0001-01-02
- external identifiers
-
- wos:000230326605403
- ISSN
- 1527-7755
- language
- English
- LU publication?
- yes
- id
- d82ab9cb-2c82-482b-adf2-93ef72567e1e (old id 226787)
- alternative location
- http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/9518
- date added to LUP
- 2016-04-01 12:25:54
- date last changed
- 2018-11-21 20:07:22
@misc{d82ab9cb-2c82-482b-adf2-93ef72567e1e,
author = {{Tanner, MM and Isola, JJ and Wiklund, T and Erikstein, B and Kellokumpu-Lehtinen, P and Malmström, Per and Wilking, N and Nilsson, J and Bergh, J}},
issn = {{1527-7755}},
language = {{eng}},
note = {{Conference Abstract}},
number = {{16S}},
pages = {{841--841}},
publisher = {{American Society of Clinical Oncology}},
series = {{Journal of Clinical Oncology}},
title = {{Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.}},
url = {{http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/9518}},
volume = {{23}},
year = {{2005}},
}